The Venture Collective is a venture capital investment firm founded in 2019, with headquarters in New York City and a presence in London. The firm focuses on early-stage investments, particularly at the Pre-Seed and Seed stages, while maintaining reserves for follow-on investments through Series A. It targets highly defensible and fast-growing companies across various sectors, including agriculture technology, artificial intelligence, clean technology, digital health, and more. Committed to fostering diversity, The Venture Collective actively seeks out diverse founding teams, believing that this approach enhances both business success and financial returns. The firm operates as an impact investment firm and is a Registered Investment Adviser, emphasizing the potential for its portfolio companies to address significant global challenges.
SimpliFed is a telehealth company founded in 2020 that offers virtual breastfeeding support to new and pregnant parents. The company focuses on providing accessible care during the peri and postnatal periods, addressing the challenges faced by parents, including sleep deprivation and concerns about infant nutrition. SimpliFed specializes in lactation and baby feeding support, as well as monitoring high-risk conditions such as hypertension and gestational diabetes. Through secure online and video-based connections, patients can engage with care navigators who guide them through their maternal care journey, helping them obtain quick answers to their questions about their infants' dietary needs.
Concert Bio
Funding Round in 2024
Concert Bio is a company that specializes in optimizing microbial communities to enhance the productivity of biotech businesses. It has developed a comprehensive platform that integrates monitoring and analytics to provide insights into microbial ecosystems. By offering targeted interventions, Concert Bio enables organizations to effectively control and improve their microbiomes, ultimately driving better performance in their operations.
Infogrid
Funding Round in 2024
Infogrid is an AI technology company that specializes in automating facilities management to create smarter buildings. By integrating Internet of Things (IoT) sensors with artificial intelligence, Infogrid streamlines and enhances building management processes, resulting in significant savings in time, costs, and environmental impact while also improving safety. The sensors used are compact, unobtrusive, and cost-effective, allowing for quick implementation. Infogrid's proprietary algorithms and machine learning capabilities convert collected data into actionable insights that promote energy efficiency and cost reduction, seamlessly integrating with existing systems. With its comprehensive platform, Infogrid enables clients to develop healthier, more sustainable, and profitable environments for their real estate and facilities teams.
Wonderbelly
Series A in 2024
Wonderbelly specializes in digestive health products, focusing on solutions for heartburn and acid reflux symptoms. The company offers a line of antacid drugs that are formulated with non-genetically modified and vegan ingredients, including calcium carbonate, vegetable cellulose, vegetable stearate, maize starch, sucrose, and natural flavors. These products aim to provide relief from gastroenterological issues such as acid indigestion and upset stomach, catering to consumers seeking effective and health-conscious remedies for their digestive discomfort.
Orbillion Bio
Venture Round in 2024
Orbillion Bio, Inc. is a food-tech company based in Fremont, California, that specializes in developing cultured meat products derived from small tissue samples taken from heritage cattle breeds. Founded in 2019, the company focuses on producing premium cell-based meat products sourced directly from farmers using heritage cell lines. Orbillion Bio aims to create delicious and nutritious food while promoting sustainability and accessibility in the meat industry.
Unnatural Products
Series A in 2023
Unnatural Products Inc. is a biotechnology company based in Santa Cruz, California, specializing in drug discovery through the innovative use of macrocyclic peptides. Founded in 2016, the company employs artificial intelligence and computational biology techniques to engineer these peptides, allowing them to target previously undruggable protein interactions. By leveraging machine learning for parallel chemical synthesis, Unnatural Products aims to optimize macrocyclic compounds efficiently, thereby accelerating the drug discovery process. This technology addresses a significant gap in therapeutic strategies, offering potential treatments for a wide range of diseases linked to difficult-to-target drug candidates.
Arogga
Seed Round in 2023
Arogga is a pioneering Bangladeshi app that facilitates the delivery of prescription and healthcare products directly to consumers' doorsteps. Users can easily upload their prescriptions, enabling quick and safe delivery of medications and a wide array of healthcare items. The platform offers a comprehensive selection of medicines, over-the-counter products, vitamins, fitness supplements, herbal products, and beauty care items. Arogga aims to enhance accessibility to healthcare services in Bangladesh and plans to expand its offerings further, positioning itself as a leading healthcare platform in the region.
Orbem
Series A in 2023
Orbem operates a sensor-based artificial intelligence breeding monitoring system designed to transform food production towards sustainability. The company utilizes AI-powered magnetic resonance imaging to automatically analyze and classify biological samples, significantly enhancing food production methods to address the demands of a growing global population. By implementing this technology, Orbem enables its customers to optimize their processing lines for greater cost efficiency, ultimately leading to the creation of high-quality products and the development of new revenue streams.
Lopay
Seed Round in 2023
Lopay is a fintech company that focuses on developing payment tools designed to empower small businesses globally. The platform offers various payment applications, allowing businesses to accept payments through their mobile devices, payment stickers, or card readers. This functionality enables independent and small businesses to conduct cashless transactions more efficiently and at a lower cost. Additionally, Lopay provides its users with instant access to their earned funds, enhancing overall financial control and flexibility for these enterprises.
Caraway
Series A in 2023
Caraway is a digital healthcare company for college women+ that provides integrated mental, reproductive and physical healthcare services. Built with students for students, Caraway arms women+ with the first personalized, equitable and digitally-accessible care solution that prioritizes their needs and concerns. With an unprecedented need for mental health resources and new barriers and persistent inequities in women’s+ health, Caraway provides access to trusted, holistic, and compassionate healthcare so women+ can get the care they need when they need it.
MDisrupt
Seed Round in 2023
MDisrupt is a health expert marketplace that connects companies in the life sciences and healthtech sectors with a network of vetted clinical, commercial, regulatory, and reimbursement experts. Utilizing an AI-powered platform, MDisrupt facilitates the process for companies to find, schedule, and engage experts for various roles, including hourly consultations, fractional positions, advisory boards, and full-time engagements. The company has worked with over 100 clients, ranging from startups to large enterprises, helping them to build, commercialize, and scale healthcare products efficiently and responsibly. Additionally, MDisrupt's platform supports clinically crowdsourced data generation, allowing both patients and providers to make informed decisions regarding healthcare.
Infogrid
Series B in 2023
Infogrid is an AI technology company that specializes in automating facilities management to create smarter buildings. By integrating Internet of Things (IoT) sensors with artificial intelligence, Infogrid streamlines and enhances building management processes, resulting in significant savings in time, costs, and environmental impact while also improving safety. The sensors used are compact, unobtrusive, and cost-effective, allowing for quick implementation. Infogrid's proprietary algorithms and machine learning capabilities convert collected data into actionable insights that promote energy efficiency and cost reduction, seamlessly integrating with existing systems. With its comprehensive platform, Infogrid enables clients to develop healthier, more sustainable, and profitable environments for their real estate and facilities teams.
Pragma Bio
Series A in 2023
Pragma Bio is a biotechnology company focused on developing microbiome-based therapies for cancer and autoimmune diseases. Founded in 2018 in Millbrae, California, by Peter McCaffrey, Kovi Bessoff, Ayin Vala, and Kareem Barghouti, the company utilizes proprietary genomic sequencing, artificial intelligence, and synthetic biology techniques to identify biomarkers and therapeutics for complex immunologic disorders. Its innovative platform aggregates extensive public and private data to create a microbiome database, enabling the discovery of connections between biologically relevant data. By using this analytical approach, Pragma Bio aims to identify novel biomarkers that can help stratify patient risk and predict clinical outcomes. The company emphasizes the importance of understanding the gut-immune axis and employs machine learning to enhance the drug discovery process, offering a more efficient alternative to traditional methods and aiming to deliver improved medicines to patients more rapidly and cost-effectively.
MDisrupt
Convertible Note in 2023
MDisrupt is a health expert marketplace that connects companies in the life sciences and healthtech sectors with a network of vetted clinical, commercial, regulatory, and reimbursement experts. Utilizing an AI-powered platform, MDisrupt facilitates the process for companies to find, schedule, and engage experts for various roles, including hourly consultations, fractional positions, advisory boards, and full-time engagements. The company has worked with over 100 clients, ranging from startups to large enterprises, helping them to build, commercialize, and scale healthcare products efficiently and responsibly. Additionally, MDisrupt's platform supports clinically crowdsourced data generation, allowing both patients and providers to make informed decisions regarding healthcare.
Gravitics
Seed Round in 2022
Gravitics, Inc. specializes in the design and manufacture of large-scale space structures, including orbital carriers, cargo logistics spacecraft, and modules for space stations. The company aims to redefine capabilities in space by providing advanced aerospace station technology that serves as foundational elements for human life in space. Utilizing next-generation hardware, Gravitics offers innovative solutions that incorporate interfacing options and robust space armor, facilitating shipyard-style fabrication within the aerospace sector. This enables clients to efficiently execute their missions in outer space and fosters the commercial development of activities in Earth orbit and beyond.
coding.bio
Seed Round in 2022
Coding.bio provides AI for cell therapies through automation and computation. They work at the intersection of computation, synthetic biology, and cell therapy. They also provide curative therapeutics for patients.
Ruby Bio
Seed Round in 2022
Ruby Bio is a biosynthesis platform focused on the production of complex, biodegradable, and non-toxic molecules. Utilizing naturally occurring yeast, the company transforms low-cost sugars into high-value products. This innovative approach allows Ruby Bio to support the creation of sustainable alternatives in personal care, home care, food, and beverage industries. By harnessing the power of biosynthesis, Ruby Bio aims to contribute to environmentally friendly solutions while addressing the growing demand for sustainable products.
Heading Health
Pre Seed Round in 2022
Heading Health is a technology-enabled mental health platform dedicated to enhancing access to affordable care. The company provides personalized treatment solutions that utilize evidence-based therapeutics and advanced technologies such as transcranial magnetic stimulation, telepsychiatry, and intramuscular ketamine. By leveraging these tools, Heading Health aims to deliver effective and convenient mental health services, helping patients achieve meaningful outcomes and improved well-being.
Stack
Seed Round in 2022
Stack is the gamified crypto investment platform specifically built for Gen-Z.
Violet
Seed Round in 2022
Violet is a platform that helps the healthcare industry deliver more inclusive services. It enables identity-centered care for everyone.
Concert Bio
Pre Seed Round in 2022
Concert Bio is a company that specializes in optimizing microbial communities to enhance the productivity of biotech businesses. It has developed a comprehensive platform that integrates monitoring and analytics to provide insights into microbial ecosystems. By offering targeted interventions, Concert Bio enables organizations to effectively control and improve their microbiomes, ultimately driving better performance in their operations.
Wonderbelly
Seed Round in 2022
Wonderbelly specializes in digestive health products, focusing on solutions for heartburn and acid reflux symptoms. The company offers a line of antacid drugs that are formulated with non-genetically modified and vegan ingredients, including calcium carbonate, vegetable cellulose, vegetable stearate, maize starch, sucrose, and natural flavors. These products aim to provide relief from gastroenterological issues such as acid indigestion and upset stomach, catering to consumers seeking effective and health-conscious remedies for their digestive discomfort.
Endpoint Health
Series A in 2022
Endpoint Health, Inc. is a precision immunology company based in Palo Alto, California, with additional offices in Michigan and Illinois. Founded in 2018, the company focuses on researching and developing therapies that integrate therapeutics, companion diagnostics, and artificial intelligence. Its mission is to enhance patient outcomes, particularly for individuals suffering from critical illnesses such as sepsis, acute respiratory distress syndrome, and COVID-19. By utilizing its proprietary AI-powered platform, OMNAI, Endpoint Health aims to identify and match effective therapies with patients who are most likely to benefit from them, moving beyond traditional one-size-fits-all approaches in drug development. Through this strategy, the company seeks to deliver personalized treatments that can significantly improve the health outcomes of patients with autoimmune and inflammatory conditions.
SimpliFed
Seed Round in 2022
SimpliFed is a telehealth company founded in 2020 that offers virtual breastfeeding support to new and pregnant parents. The company focuses on providing accessible care during the peri and postnatal periods, addressing the challenges faced by parents, including sleep deprivation and concerns about infant nutrition. SimpliFed specializes in lactation and baby feeding support, as well as monitoring high-risk conditions such as hypertension and gestational diabetes. Through secure online and video-based connections, patients can engage with care navigators who guide them through their maternal care journey, helping them obtain quick answers to their questions about their infants' dietary needs.
Knoma
Venture Round in 2022
Knoma Ltd operates an online platform that facilitates loans for educational courses, focusing on bridging the digital skills gap in a rapidly evolving global economy. Established in 2018 and based in London, the platform allows users to access a wide range of online courses, including subjects like cybersecurity and software development. Knoma enables learners to finance their education through flexible monthly payments, allowing them to borrow up to £10,000, which can be repaid over a twelve-month period without any interest or fees. By partnering with leading coding and tech schools, Knoma aims to make lifelong learning more accessible and affordable, thereby supporting individuals in enhancing their technical, digital, and data skills for future career advancement.
Ellevest
Series B in 2022
Ellevest, Inc. is an investment management firm founded in 2014 and based in New York City, focusing primarily on providing financial services to women. The firm manages customized client portfolios across various asset classes globally, employing fundamental analysis and a top-down approach in its investment strategy. Ellevest has developed a digital investment platform that offers a personalized experience, utilizing proprietary algorithms tailored to women's financial needs, including salary peaks and goal-specific portfolios. This platform aims to empower female investors by helping them take control of their investments and achieve their financial goals through a user-friendly interface and thoughtful portfolio construction.
Everna
Seed Round in 2022
Everna Limited is a biotechnology company based in London, United Kingdom, focused on developing novel therapeutics aimed at mitigating the effects of aging on cellular functions. Founded in 2016, the company specializes in creating drugs for the treatment of age-related diseases, including neurodegenerative disorders, atherosclerosis, and non-alcoholic fatty liver disease. Everna employs innovative stem cell models to facilitate disease-modifying effects, enabling patients to combat various ailments associated with aging.
Helaxy
Seed Round in 2022
Helaxy is a Singapore-based company founded in 2020 that focuses on developing fluidic cards for next-generation sequencing (NGS) preparation. These innovative solutions are designed for specialty laboratories, allowing clinicians to significantly reduce hands-on time while minimizing errors associated with manual pipetting. By streamlining the process, Helaxy's technology helps decrease the waste of reagents and plastic consumables, thereby enhancing efficiency in laboratory operations.
Gravitics
Seed Round in 2022
Gravitics, Inc. specializes in the design and manufacture of large-scale space structures, including orbital carriers, cargo logistics spacecraft, and modules for space stations. The company aims to redefine capabilities in space by providing advanced aerospace station technology that serves as foundational elements for human life in space. Utilizing next-generation hardware, Gravitics offers innovative solutions that incorporate interfacing options and robust space armor, facilitating shipyard-style fabrication within the aerospace sector. This enables clients to efficiently execute their missions in outer space and fosters the commercial development of activities in Earth orbit and beyond.
HelixNano
Convertible Note in 2022
HelixNano is a biotechnology company focused on leveraging artificial intelligence and synthetic biology to develop innovative solutions for genetic diseases. Initially concentrating on cancer vaccines, the company is now pivoting to create COVID-19 vaccine candidates that prioritize precision and safety. HelixNano's platform enables the reliable expression of transgenes in humans, facilitating advancements in gene therapies and genome engineering. The company aims to not only address the current COVID-19 pandemic but also to develop vaccines that provide protection against all future coronaviruses. Through its work, HelixNano seeks to enable previously unattainable applications in both human and non-human biology, ultimately improving patient outcomes across a range of diseases.
Orbem
Seed Round in 2022
Orbem operates a sensor-based artificial intelligence breeding monitoring system designed to transform food production towards sustainability. The company utilizes AI-powered magnetic resonance imaging to automatically analyze and classify biological samples, significantly enhancing food production methods to address the demands of a growing global population. By implementing this technology, Orbem enables its customers to optimize their processing lines for greater cost efficiency, ultimately leading to the creation of high-quality products and the development of new revenue streams.
Radian
Seed Round in 2022
Radian Aerospace is innovating the aerospace sector with its next-generation spaceplane, which is the first fully reusable vehicle designed for horizontal takeoff and landing. This single-stage to orbit spacecraft aims to facilitate the transportation of people and light cargo to low Earth orbit as well as various terrestrial locations, operating in a manner similar to conventional aircraft. Radian's vehicles are constructed from advanced materials that can endure extreme conditions and are equipped with propulsion technologies that enhance maneuverability and overall performance. Additionally, they incorporate satellite systems that improve communication capabilities, thereby supporting enhanced missions and operational efficiency within the space industry.
Chingari
Series A in 2022
Chingari is a short-video sharing platform designed to connect talented individuals in India. It enables users to create, edit, and share short videos, along with various multimedia content such as audio clips, GIF stickers, and photos. The application is primarily available for Android users and allows for instant sharing on third-party social media platforms. Chingari monetizes its services through in-app advertisements, providing a space for users to showcase their creativity while engaging with a broader audience.
Epoch Biodesign
Seed Round in 2022
Epoch Biodesign focuses on creating natural solutions to address climate challenges through the development of innovative enzymes. By integrating insights from nature with expertise in computational and biological sciences, the company enables the biorecycling of plastic waste into everyday chemicals. Their enzymatic process is tunable, allowing for efficient conversion of unrecyclable plastics into low-carbon alternatives. Epoch Biodesign's approach not only facilitates the recycling of plastic waste but also enhances the discovery and development of products using complex proteins, positioning the company as a significant player in advancing sustainable practices in waste management.
Jefa
Seed Round in 2021
Jefa is a digital financial platform focused on empowering women by providing them with a user-friendly app that facilitates financial management. Initially launched in Mexico, the platform offers access to a comprehensive financial marketplace, enabling users to send and receive money, automate service payments, and make purchases without incurring hidden fees or commissions. Jefa aims to deliver an affordable, convenient, and secure solution that enhances women's financial independence and decision-making.
Intellihealth
Seed Round in 2021
Intellihealth develops medical technology software to diagnose obesity-related diseases. The company's flagship product, Evolve, enables medical providers to offer effective medical obesity treatment to new and existing patients, both via telehealth and in person.
Altru
Pre Seed Round in 2021
Altru is a social platform designed to connect companies with nonprofit initiatives, aiming to make corporate giving both impactful and profitable. By facilitating partnerships between activist-creators, brands, and individuals, Altru enables businesses to engage with social and environmental causes that resonate with their customers. The platform not only promotes corporate social responsibility but also emphasizes the importance of aligning business objectives with societal needs. With a significant portion of the global population believing that companies should address social and environmental issues, Altru positions itself as a valuable tool for businesses looking to enhance community engagement and achieve positive returns on their social investments.
Elysium
Series C in 2021
Elysium Health, Inc. develops and produces health supplements focused on cellular health, long-term brain health, and biological age testing. Founded in 2014 and based in New York, the company sells its products online, aiming to enhance health and longevity through scientifically backed solutions. Elysium collaborates with scientists, clinicians, and health professionals globally to identify and formulate natural compounds. Its flagship product features a proprietary combination of ingredients designed to support overall well-being at the cellular level, addressing contemporary health challenges with a foundation in scientific research.
SNAFU Records
Venture Round in 2021
SNAFU Records AB is a music company based in Stockholm, Sweden, founded in 2018. The company specializes in utilizing algorithms to analyze data from major music platforms such as Spotify and YouTube. By scanning this data, SNAFU Records identifies artists and songs that exhibit significant potential and stand out in the competitive music landscape. This innovative approach allows the company to discover emerging talent and promote unique musical works effectively.
HelixNano
Series A in 2021
HelixNano is a biotechnology company focused on leveraging artificial intelligence and synthetic biology to develop innovative solutions for genetic diseases. Initially concentrating on cancer vaccines, the company is now pivoting to create COVID-19 vaccine candidates that prioritize precision and safety. HelixNano's platform enables the reliable expression of transgenes in humans, facilitating advancements in gene therapies and genome engineering. The company aims to not only address the current COVID-19 pandemic but also to develop vaccines that provide protection against all future coronaviruses. Through its work, HelixNano seeks to enable previously unattainable applications in both human and non-human biology, ultimately improving patient outcomes across a range of diseases.
GoalBased Investors
Seed Round in 2021
GoalBased Investors operates a digital platform designed to facilitate goal-based financial planning and advice. Founded in 2019 by Chip Castille and based in New York, the company aims to make financial planning accessible to individuals of all financial literacy levels. The platform allows users to create and share financial plans with advisors, fostering collaborative improvement. It simplifies the process of setting and achieving financial goals by matching users with expert advice, all within a streamlined and engaging experience. Through this approach, GoalBased Investors enhances conversations around financial objectives, ultimately empowering clients to reach their financial aspirations.
BettaF!sh
Seed Round in 2021
BettaF!sh is a Berlin-based manufacturing company established in 2020 that specializes in creating plant-based tuna alternatives. The company focuses on producing authentic-tasting vegan tuna using proteins derived from cultivated European seaweed. By transforming this nutritious and regenerative resource, BettaF!sh offers consumers an eco-friendly seafood option that caters to the growing demand for sustainable food products.
BlockFi
Series D in 2021
BlockFi, Inc. is a New York-based financial services company that specializes in providing wealth management products for cryptocurrency investors. Founded in 2017, it offers interest-bearing accounts that allow clients to earn yields on their Bitcoin, Ether, and Gemini Dollar holdings. The company also facilitates secured loans in USD, where clients can collateralize their loans with cryptocurrency assets. Additionally, BlockFi provides a trading platform for exchanging various cryptocurrency pairs and customizable lending options for institutions. By leveraging a sophisticated infrastructure that integrates with multiple blockchains, BlockFi aims to enhance liquidity and efficiency in digital financial markets, catering to the needs of both individual and institutional clients.
Axiom Space
Series B in 2020
Axiom Space, Inc. is a Houston, Texas-based company founded in 2016 that focuses on developing and operating commercial space station modules connected to the International Space Station (ISS). The company offers human spaceflight services to government astronauts, tourists, and private enterprises, facilitating research, manufacturing, and testing of space exploration technologies. Axiom Space aims to provide universal access to the ISS, conducting missions for both national and private astronauts, and enabling clients from various sectors to engage in space initiatives. The company leverages its platform in Low Earth Orbit and extensive experience in human spaceflight management to create new opportunities for advanced industries and future space exploration endeavors.
Infogrid
Series A in 2020
Infogrid is an AI technology company that specializes in automating facilities management to create smarter buildings. By integrating Internet of Things (IoT) sensors with artificial intelligence, Infogrid streamlines and enhances building management processes, resulting in significant savings in time, costs, and environmental impact while also improving safety. The sensors used are compact, unobtrusive, and cost-effective, allowing for quick implementation. Infogrid's proprietary algorithms and machine learning capabilities convert collected data into actionable insights that promote energy efficiency and cost reduction, seamlessly integrating with existing systems. With its comprehensive platform, Infogrid enables clients to develop healthier, more sustainable, and profitable environments for their real estate and facilities teams.
Axiom Space
Series A in 2019
Axiom Space, Inc. is a Houston, Texas-based company founded in 2016 that focuses on developing and operating commercial space station modules connected to the International Space Station (ISS). The company offers human spaceflight services to government astronauts, tourists, and private enterprises, facilitating research, manufacturing, and testing of space exploration technologies. Axiom Space aims to provide universal access to the ISS, conducting missions for both national and private astronauts, and enabling clients from various sectors to engage in space initiatives. The company leverages its platform in Low Earth Orbit and extensive experience in human spaceflight management to create new opportunities for advanced industries and future space exploration endeavors.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.